Cutler Group LP Lava Therapeutics Nv Call Options Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
Call Options
1 transactions
Others Institutions Holding LVTX
# of Institutions
22Shares Held
4.94MCall Options Held
17.9KPut Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$3.34 Million0.33% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.97MShares$3.17 Million1.97% of portfolio
-
Bruce & Co., Inc. Chicago, IL522KShares$840,2170.29% of portfolio
-
Pathway Financial Advisors LLC103KShares$165,0250.02% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$104,6500.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $41.5M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...